Back
ACVC Premium Access

P2Y12 monotherapy versus standard dual antiplatelet therapy after percutaneous coronary intervention: a systematic review and meta-analysis

Session: Risk factors, prevention, and pharmacotherapy
Topic: Antiplatelet Drugs
Speaker: Doctor B. Buot (Quezon City, PH)
Event: ESC Acute CardioVascular Care 2024

Congress Presentation

Add to my library

Like

About the speaker

Doctor Bea Christine Joyce Buot

St. Luke's College of Medicine, Quezon City (Philippines)
0 follower

6 more presentations in this session

Cardiac rehabilitation makes a difference: lipid control targets and prognosis.

Speaker: Mrs M. Lucas Garcia (Sevilla, Spain, ES)

Access
Abstract
Slides
Like
Thumbnail

The lipid profile of the young patient with ischemic heart disease. Do these patients meet the goals?

Speaker: Doctor M. Pelaz Sanchez (Seville, ES)

Access
Abstract
Slides
Like
Thumbnail

Prescription of lipid-lowering therapy, LDLc control, and risk of MACE in patients after ST-elevation myocardial infarction in Mexico

Speaker: Miss S. Hernandez Pastrana (Mexico City, MX)

Access
Abstract
Slides
Like
Thumbnail

Risk factors for intensive care admission in pediatric patients with COVID-19 - results of the German na-tionwide inpatient sample

Speaker: Doctor K. Keller (Mainz, DE)

Access
Abstract
Slides
Like
Thumbnail

Combining rivaroxaban with aspirin for peripheral artery disease: an in-depth systematic review and meta-analysis

Speaker: Doctor B. David (Global City, PH)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Risk factors, prevention, and pharmacotherapy

Speakers: Doctor B. Buot, Mrs M. Lucas Garcia, Doctor M. Pelaz Sanchez, Miss S. Hernandez Pastrana, Doctor K. Keller...
Access
Like
Thumbnail

About the event

Image

ESC Acute CardioVascular Care 2024

8 March - 10 March 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources